Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
暂无分享,去创建一个
T. Schiano | P. Perumalswami | J. Doucette | M. Fiel | L. Kim-schluger | Charissa Y. Chang | S. Florman | J. Odin | J. Ahmad | Lawrence U. Liu | N. Bach | H. Sima | V. Khaitova | P. Grewal | K. Lim | Maria Chernyiak | M. Fiel